Telemedicine During and After COVID-19

Telemedicine has emerged as an essential tool that allows healthcare providers to continuing seeing patients during the COVID-19 pandemic. Governments around the world have worked to promote utilization of telehealth to keep their citizens healthy and at home while hospitals and other healthcare facilities face an influx of COVID-19 patients. From issuing waivers, expanding coverage options and reimbursement, and temporarily removing some technology and privacy constraints that have historically limited telehealth adoption, the regulatory response to make telehealth more accessible has been swift. McDermott’s team is closely watching the evolving legal landscape and has prepared videos, webinars, articles and other resources to help your organization comply with these changing standards and implement telehealth solutions.

pointer
×

Title Here

Content Here

Medicare Reimbursement for Telehealth Services after a Public Health Emergency
pointer
×

Title Here

Content Here

Implementing Digital Health Technologies

Videos

How the CARES Act Affects Telehealth and Digital Health

Navigating Telehealth During COVID-19

Webinar Replays

Around the Corner Series: The Future of Telehealth After COVID-19

Around the Corner Series: The Future of Telehealth After COVID-19

CALL HOTLINE     EMAIL TASK FORCE    SUBSCRIBE TO UPDATES Resource Center Home | Webinar ReplaysRead the Transcript   Alumni     Temporary Visitor Policy     Legal Notices/Imprint     Privacy & Cookies Policy     Terms of Use     Client Connect     McDermott...

State and Federal Coronavirus Issues

State and Federal Coronavirus Issues

CALL HOTLINE     EMAIL TASK FORCE    SUBSCRIBE TO UPDATES Read the Transcript   Alumni     Temporary Visitor Policy     Legal Notices/Imprint     Privacy & Cookies Policy     Terms of Use     Client Connect     McDermott Remote Desktop     Contact...

Telehealth Reimbursement During COVID-19

Telehealth Reimbursement During COVID-19

CALL HOTLINE     EMAIL TASK FORCE    SUBSCRIBE TO UPDATES Read the Transcript   Alumni     Temporary Visitor Policy     Legal Notices/Imprint     Privacy & Cookies Policy     Terms of Use     Client Connect     McDermott Remote Desktop     Contact...

Telehealth COVID-19 Follow-up Briefing

Telehealth COVID-19 Follow-up Briefing

CALL HOTLINE     EMAIL TASK FORCE    SUBSCRIBE TO UPDATES Read the TranscriptWelcome and thank you for joining us today for this telemedicine briefing update. My name is Lisa Mazur. I'm a partner in the McDermott Will & Emery health group. And I'm joined today by...

Telehealth COVID-19 Briefing

Telehealth COVID-19 Briefing

CALL HOTLINE     EMAIL TASK FORCE    SUBSCRIBE TO UPDATES Read the Transcript   Alumni     Temporary Visitor Policy     Legal Notices/Imprint     Privacy & Cookies Policy     Terms of Use     Client Connect     McDermott Remote Desktop     Contact...

Legal Insights

Insights

CMS UPDATES COVID-19 GUIDANCE FOR MA ORGANIZATIONS AND PART D SPONSORS, ADDRESSES THE STATUS OF TELEHEALTH VISITS FOR RISK ADJUSTMENT
05/01/2020

BILL EXTENDS MEDICARE TELEHEALTH COVERAGE FOR THERAPY PROVIDERS
04/29/2020

FDA ISSUES ENFORCEMENT POLICY FOR DIGITAL HEALTH THERAPEUTIC DEVICES FOR PSYCHIATRIC DISORDERS DURING COVID-19
04/21/2020

COVID-19 RELIEF LAW INCLUDES MAJOR CHANGES TO SUBSTANCE USE DISORDER CONFIDENTIALITY LAW
04/15/2020

MEDICARE RESOURCES AND INFORMATION FOR HOME HEALTH AND HOSPICE AGENCIES DURING THE COVID-19 PANDEMIC
04/10/2020

FLEXIBILITIES FOR RURAL HEALTH CENTERS, FEDERALLY QUALIFIED HEALTH CENTERS DURING COVID-19
04/06/2020

DEA PROVIDES ADDITIONAL GUIDANCE REGARDING PRESCRIPTION AND OTHER POLICIES DURING THE COVID-19 PUBLIC HEALTH EMERGENCY
04/01/2020

OTS – CMS ISSUES BROAD PACKAGE OF BLANKET WAIVERS UNDER SECTION 1135
03/31/2020

CMS ISSUES ADDITIONAL GUIDANCE ON EMTALA REQUIREMENTS FOR HOSPITALS
03/31/2020

SECRETARY AZAR CALLS ON GOVERNORS TO MODIFY REGULATIONS TO EXPAND HEALTHCARE WORKFORCE
03/26/2020

OIG CLARIFIES SCOPE OF TELEHEALTH COPAYMENT WAIVER
03/25/2020

OCR ENFORCEMENT WAIVERS OF CERTAIN HIPAA REQUIREMENTS IN FURTHERANCE OF TELEHEALTH DURING COVID-19 PANDEMIC
03/25/2020

LEGAL IMPLICATIONS OF COVID-19 FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES IN FRANCE
03/25/2020

FDA OFFERS GUIDANCE ON CLINICAL TRIALS DURING COVID-19 PANDEMIC
03/23/2020

OCR ENFORCEMENT WAIVERS OF CERTAIN HIPAA REQUIREMENTS IN FURTHERANCE OF TELEHEALTH DURING COVID-19 PANDEMIC
03/23/2020

HOW TO ADDRESS BENEFICIARY INDUCEMENT QUESTIONS DURING COVID-19
03/20/2020

CMS GUIDANCE AND WAIVERS FOR MA AND PART D PLANS’ RESPONSE TO COVID-19
03/18/2020

DEA: IN-PERSON VISIT NOT REQUIRED FOR CONTROLLED SUBSTANCES PRESCRIPTION DURING PUBLIC HEALTH EMERGENCY
03/18/2020

HSA ELIGIBILITY NOT DISRUPTED BY COVID-19 (NOVEL CORONAVIRUS) TESTING AND TREATMENT
03/11/2020

BIPARTISAN BILL RELAXES FEDERAL TELEHEALTH REQUIREMENTS IN THE WAKE OF COVID-19
03/05/2020

PRIVACY, HIPAA, SECURITY AND GDPR – COVID-19 CONSIDERATIONS
03/2020

Podcasts

Healthcare Preview: Week of April 6
Health Policy Breakroom Ep. 18 – Overview of the CARES Act
Health Policy Breakroom Ep. 19: CARES Implementation and Bill 4
Healthcare Preview: Week of Mar. 30

Subscribe and/or Contact the Task Force

What would you like to do?



By submitting this form, you agree to consent to processing and accept the terms of our privacy policy.

XING


Related Site:     McDermott+ Consulting

Attorney Advertising ©2020 McDermott Will & Emery